Toggle navigation
Home
Search
Services
Blog
Contact
About
Intrabody Control of Expanded-Repeat Neurodegeneration
Messer, Anne
Intraimmune Therapies, Inc., Boston, MA, United States
Search 27 grants from Anne Messer
Search grants from Intraimmune Therapies, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
PrEP My Way: A Novel PrEP Delivery System to Meet the Needs of Young African Women
Phenotyping embryonic mammalian heart function using OCT
The Role of Polyadenylation in RNA Turnover
Alpha 2 Macroglobulin Variant Linked to Late Onset Ad
Synaptic Correlates of Vocal Learning
Recently added grants:
Understanding the mechanism of action for anticancer sulfonamides that target splicing
Directing the metabolic fate of CAR T cells
(PQ5) Consequences of imbalanced mitophagy and mitochondrial biogenesis in cancer
?-3 fatty acid-derived mediators promote resolution of inflammation: Uncovering new strategies for preventing colitis-associated colon cancer
Project 1: Effect of Iron Deprivation on H. pylori-induced Gastric Carcinogenesis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Small Business Technology Transfer (STTR) Grants - Phase II (R42)
Project #
2R42NS038002-02
Application #
6073705
Study Section
Special Emphasis Panel (ZRG1-MDCN-3 (02))
Program Officer
Oliver, Eugene J
Project Start
1998-08-01
Project End
2002-01-31
Budget Start
2000-02-15
Budget End
2001-01-31
Support Year
2
Fiscal Year
2000
Total Cost
$250,000
Indirect Cost
Institution
Name
Intraimmune Therapies, Inc.
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02114
Related projects
NIH 2001
R42 NS
Intrabody Control of Expanded-Repeat Neurodegeneration
Messer, Anne / Abgenix, Inc.
$250,000
NIH 2000
R42 NS
Intrabody Control of Expanded-Repeat Neurodegeneration
Messer, Anne / Intraimmune Therapies, Inc.
$250,000
Comments
Be the first to comment on Anne Messer's grant